Article Text

PDF
No gain – no pain?
  1. Cindy Shin-Yi Lin1,
  2. Michelle A Farrar2
  1. 1Faculty of Medicine, Translational Neuroscience Facility, School of Medical Science, University of New South Wales, New South Wales, Sydney, Australia
  2. 2Sydney Children's Hospital and School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia
  1. Correspondence to Dr Cindy Shin-Yi Lin, Faculty of Medicine, Translational Neuroscience Facility, School of Medical Science, University of New South Wales, NSW 2052 Sydney, Australia; c.lin{at}unsw.edu.au

Statistics from Altmetric.com

Pain is one of the most pervasive symptoms in clinical medicine and always presents a challenge, both in terms of diagnosis and management. Abnormal voltage gated sodium channels (VGSCs) are emerging as key determinants in painful neuropathies. Genetic, metabolic or immunological factors have independently been demonstrated to alter ion channel properties, providing insight into complex pathophysiological mechanisms in pain. Specifically, modification of the Nav 1.7 isoform, encoded by the SCN9A gene, can profoundly impact pain sensitivity.1 Nav 1.7 is expressed in the peripheral nervous system in sensory and sympathetic neurons. Activating mutations in SCN9A produce severe pain due to gain-of-function in …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles